Similarly, furanodienone induces apoptosis in CRC cells through ROS production originating from NADPH oxidase 4 [46], and glycyrrhetinic acid activates NADPH oxidases to promote ROS accumulation and ferroptosis in triple-negative breast cancer cells [47]. Here, FMO5 is linked to triple-negative breast carcinoma.